drugset / Trial / NCT06698198
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)
RandomizedParallel-groupTriple-blindPrevention
Summary
This was a Phase I, randomized, active-controlled, observer-blinded, multi-center study to assess the safety and the immunogenicity of 4 Pneumococcal Conjugate Vaccines (PCV) candidates in parallel with Prevnar 13, in Healthy Adults (19-49 years) in the United States.
Timeline
- Start
- 2018-12-03
- Primary completion
- 2019-09-30
- Completion
- 2019-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prevnar 13 | Vaccine | — | Intramuscular |
| Subject | SP0202-I | Unknown | — | Intramuscular |
| Subject | SP0202-II | Unknown | — | Intramuscular |
| Subject | SP0202-III | Unknown | — | Intramuscular |
| Subject | SP0202-IV | Unknown | — | Intramuscular |